ReviewMolecular and cellular biochemistry2026
Five key challenges for the plasma membrane insertion of nicotinic acetylcholine receptors in cellular model systems.
Review in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Insertion of nicotinic acetylcholine receptors (nAChR) into the plasma membrane depends on their movement, organization and incorporation of lipid components. nAChRs are a highly investigated target in current therapeutic research, including studies on channel opening and ion flow. Both areas require suitable cellular model systems, which are not readily available. Notably, muscle-type nAChRs can be generated in new transgene model systems. Despite minor successes, none of the existing model systems perfectly replicate the clustered, high-density receptors and their unique arrangement at the cell surface. This review examines the challenges which must be overcome to enable increased nAChR insertion into plasma membranes in artificial systems. We present models such as lipid rafts and the orchestration of protein-lipid interactions, and emphasize their relationship to nAChRs as a meshwork. Further studies reveal that membranes require particular lipid ingredients for the process of nAChR insertion. We examine the use of a picket-fence model with an extension of the dystrophin-associated glycoprotein complex (DGC) as a specialized picket for nAChR anchoring, clustering, and nanodomain formation. We specifically present the function of DGC as a special picket in nAChR platform formation for microaggregates and the signaling pathways involved in protein embedding in this DGC model. This provides insights into the issue of why nAChR insertion is minimal in artificial systems. The main aspects are evaluated by applying our transgene cellular model system. If these problems could be solved, it will be possible to develop improved cellular model systems with higher nAChR inserted densities in the future.
Indexed as
Identifiers
41296272What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.